Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × apalutamide × 30 days × Clear all

Phase

Phase 3 10 Phase 2 10 Phase 1 3 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Neoplasm Metastasis 1

Interventions

Cisplatin 15 Magnetic Resonance Spectroscopy 14 Specimen Handling 12 Gemcitabine 9 Carboplatin 9 pembrolizumab 8 Platinum 8 Nivolumab 8 1,2-diaminocyclohexaneplatinum II citrate 8 Paclitaxel 7 atezolizumab 6 Radiotherapy 6 Doxorubicin 6 Radiation 5 Biopsy 5 Bevacizumab 5 Rituximab 4 Prednisone 4 Pemetrexed 4 Immunoglobulin G 4 Disulfides 4 Cyclophosphamide 4 Vincristine 3 Radiotherapy, Intensity-Modulated 3 Methotrexate 3 Ipilimumab 3 Docetaxel 3 Cytarabine 3 Capecitabine 3 Androgen Antagonists 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04787744 2026-04-08

VA STARPORT

VA Office of Research and Development

Phase 2/3 Recruiting

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡